Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/02/2014US20140296276 Sequestered antagonist formulations
10/02/2014US20140296275 Combinations of an Opioid/TLR4 Antagonist and an Alpha-2-Delta Ligand for Use in the Treatment of Pain
10/02/2014US20140296274 Treatment of pain using a composition of opioid/Toll-like receptor 4 antagonists and dextro enantiomers thereof
10/02/2014US20140296273 Method and Compositions for Treatment or Prevention of Inflammatory Conditions
10/02/2014US20140296272 Thieno [2, 3-b] pyridine derivatives as viral replication inhibitors
10/02/2014US20140296271 Kinase inhibitor
10/02/2014US20140296270 STAT3 Inhibitors
10/02/2014US20140296267 Solid dispersions of a erb2 (her2) inhibitor
10/02/2014US20140296266 Therapeutic compounds
10/02/2014US20140296264 Mgmt inhibitor combinations for the treatment of neoplastic disorders
10/02/2014US20140296262 Method to Treat Premature Ejaculation in Humans
10/02/2014US20140296259 4-Amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and their use as antiviral active substances
10/02/2014US20140296258 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibiton
10/02/2014US20140296257 High-Loading Water-Soluable Carrier-Linked Prodrugs
10/02/2014US20140296255 Lysine demethylase inhibitors for thrombosis and cardiovascular diseases
10/02/2014US20140296250 Trazodone and trazodone hydrochloride in purified form
10/02/2014US20140296244 Method for treating a pulmonary hypertension condition
10/02/2014US20140296243 Bromodomain inhibitors and uses thereof
10/02/2014US20140296242 Compounds for treating cancer, for administering, and for pharmaceutical compositions
10/02/2014US20140296240 Substituted aminopropionic derivatives as neprilysin inhibitors
10/02/2014US20140296238 Dihydropyrazoles
10/02/2014US20140296236 Quinolines as fgfr kinase modulators
10/02/2014US20140296231 Amino-substituted imidazopyridazines
10/02/2014US20140296228 Inhibitors of human immunodeficiency virus replication
10/02/2014US20140296225 Inhibitors of the Renal Outer Medullary Potassium Channel
10/02/2014US20140296224 Quinoline derivatives as pi3 kinase inhibitors
10/02/2014US20140296223 Method for regulating skin pigmentation
10/02/2014US20140296219 Compounds for modulating tlr2
10/02/2014US20140296217 Medicaments for the treatment or prevention of fibrotic diseases
10/02/2014US20140296211 Anavex2-73 and certain anticholinesterase inhibitors composition and method for neuroprotection
10/02/2014US20140296210 Pharmacological treatment of cognitive impairment
10/02/2014US20140296208 Kinase inhibitors
10/02/2014US20140296203 Novel compounds that are erk inhibitors
10/02/2014US20140296201 Inhibitors of influenza viruses replication
10/02/2014US20140296197 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
10/02/2014US20140296196 Nk1 antagonists
10/02/2014US20140296195 Method for the treatment of central nervous system cancers and compositions related thereto
10/02/2014US20140296194 Prevention or attenuation of neuropathic pain and kidney injury by tauroursodeoxycholic acid
10/02/2014US20140296193 Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
10/02/2014US20140296192 Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid
10/02/2014US20140296190 Marketing the use of 25-hydroxyvitamin d3 to enhance cognition
10/02/2014US20140296189 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
10/02/2014US20140296188 New therapy for transthyretin-associated amyloidosis
10/02/2014US20140296179 Nutritional composition comprising immunoglobulins and oligosaccharides
10/02/2014US20140296178 Combination Therapy with a Gallium Complex
10/02/2014US20140296176 Combination cancer therapy with an hsp90 inhibitor and an antimetabolite
10/02/2014US20140296175 Composition and method for inducing epo-mediated haemoglobin expression and mitochondrial biogenesis in nonhaematopoietic cell
10/02/2014US20140296174 Silk-based multifunctional biomedical platform
10/02/2014US20140296173 Stable nanocomposition comprising epirubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014US20140296171 Novel urea compounds
10/02/2014US20140296170 Pharmaceutical composition for prevention or treatment of bone diseases comprising spinasterol glucoside derivative
10/02/2014US20140296167 Glycosylation site-specific antibodies and anti-cancer compounds
10/02/2014US20140296166 Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction
10/02/2014US20140296159 Method for Therapeutic Replenishment and Enrichment of Ocular Surface Lubrication
10/02/2014US20140296141 Compositions and Methods for Treating Obesity, Obesity Related Disorders and for Inhibiting the Infectivity of Human Immunodeficiency Virus
10/02/2014US20140296136 Hcv ns3 protease inhibitors
10/02/2014US20140296135 Medicament for the treatment of fungal infections particularly aspergillosis
10/02/2014US20140296133 Sila analogs of oxazolidinone derivatives and synthesis thereof
10/02/2014US20140296128 Materials and methods for treatment of cancer and identification of anti-cancer compounds
10/02/2014US20140295549 Methods and compositions for inducing apoptosis by stimulating er stress
10/02/2014US20140295543 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
10/02/2014US20140295009 Composition and method for boosting immunological response
10/02/2014US20140295005 Formulation of Curcumin With Enhanced Bioavailability of Curcumin and Method of Preparation and Treatment Thereof
10/02/2014US20140295003 Methods for improving health in canines
10/02/2014US20140295002 Methods for improving health in humans
10/02/2014US20140295001 Herbal/organic composition for the management of pain
10/02/2014US20140294999 Natural weight reduction health composition and application thereof
10/02/2014US20140294997 Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodites to microbiota of firmuctes phylum
10/02/2014US20140294995 Lozenge for treating sore throat, hoarseness and associated dry cough, and inflammatory diseases of the oral and pharyngeal cavity
10/02/2014US20140294994 Pharmaceutical composition for elimination of cancer stem cells
10/02/2014US20140294993 Method for treatment of mesothelioma
10/02/2014US20140294991 Medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent
10/02/2014US20140294988 Skin treatment formula for psoriasis
10/02/2014US20140294987 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
10/02/2014US20140294986 Microsphere Drug Delivery System for Sustained Intraocular Release
10/02/2014US20140294984 Compacted rumen protected nutrient pellets and method of manufacture
10/02/2014US20140294983 Stable nanocomposition comprising doxorubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014US20140294980 Sustained release particle formulations
10/02/2014US20140294979 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression
10/02/2014US20140294977 Radiation-Sterilized Biodegradable Drug Delivery Composition
10/02/2014US20140294974 Cosmetic composition
10/02/2014US20140294973 Pharmaceutical compositions of hydrophobic camptothecin derivatives
10/02/2014US20140294972 Oral Suspension
10/02/2014US20140294970 Stabilized pharmaceutical sub-micron suspensions and methods of forming same
10/02/2014US20140294967 Stable nanocomposition comprising paclitaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014US20140294966 Stable nanocomposition comprising docetaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014US20140294964 Compositions and methods for treating cancer with dacarbazine nanoemulsions
10/02/2014US20140294959 Pharmaceutical Composition of Rosuvastatin Calcium
10/02/2014US20140294957 Niclosamide for the treatment of cancer metastasis
10/02/2014US20140294956 Gastric retentive extended release pharmaceutical compositions
10/02/2014US20140294954 Misuse preventative, controlled release formulation
10/02/2014US20140294953 Abuse-Resistant Formulations
10/02/2014US20140294951 Oral formulations mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2D
10/02/2014US20140294950 Methods of treating obesity in responder and non-responder populations
10/02/2014US20140294947 Tamper resistant immediate release formulations
10/02/2014US20140294934 Cationic lipids for therapeutic agent delivery formulations
10/02/2014US20140294933 Composition for delivery of angiogenesis inducing molecule and artificial tissue prepared by the composition
10/02/2014US20140294932 Temperature sensitive liposome including cationic lipid and use thereof
10/02/2014US20140294931 Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
10/02/2014US20140294929 Compositions for delivery of cargo such as drugs proteins and/or genetic materials
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 7860